Loading…

Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)

Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among h...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2017-09, Vol.17 (1), p.614-614, Article 614
Main Authors: He, Xiaoguang, Xie, Mingyu, Li, Siping, Ye, Junqin, Peng, Qi, Ma, Qiang, Lu, Xiaomei, Zhong, Baimao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23
cites cdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23
container_end_page 614
container_issue 1
container_start_page 614
container_title BMC infectious diseases
container_volume 17
creator He, Xiaoguang
Xie, Mingyu
Li, Siping
Ye, Junqin
Peng, Qi
Ma, Qiang
Lu, Xiaomei
Zhong, Baimao
description Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China. Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance. Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria. S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.
doi_str_mv 10.1186/s12879-017-2710-4
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7128d55ebf5a4887ad9bcc15fbe8750a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A509101266</galeid><doaj_id>oai_doaj_org_article_7128d55ebf5a4887ad9bcc15fbe8750a</doaj_id><sourcerecordid>A509101266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</originalsourceid><addsrcrecordid>eNqNkstu1DAUhiMEoqXwAGyQJTatRIrt3OwN0mi4jVSpEret5dhOxqPEntoOZXgf3pMTppQOYoGycHT8nd8-v_8se0rwOSGsfhkJZQ3PMWly2hCcl_eyY1I2JKdFUd6_83-UPYpxgwFklD_MjihjvCC8Os5-LFyyo1XBt1YOKJhoY5JOGWQdaqVKJsz1rUxr3xsXkRy969Hax61NcrDfjUZqbQcdjEPXNq2R8uM4OZt2SKqryQYABn9twqy9tUEmH3YoBZCGIzqjkvUgC6e9BuF-ku4FWq6tk-iUYgLXx6Q-e5w96OQQzZOb9ST7_PbNp-X7_OLy3Wq5uMhVTVnKqS4wJQVnJa5ZUROjy5Z2GuZmdadZo7hiVHHDu5aVda3bmpZUt6ToOC6ZosVJttrrai83YhvsKMNOeGnFr4IPvZAhWTUY0YD3uqpM21WyZKyRmrdKkaprDWsqLEHr1V5rO7Wj0co4GHo4ED3ccXYtev9VVBUvKzxf5vRGIPirycQkRhuVGQbpjJ-iILxghPOSlIA-_wvd-Ck4sAooEOMVw-QP1UsYAMz38zPMomIBDMGE1jVQ5_-g4NMGcuKd6SzUDxrODhqASeZb6uUUo1h9_PD_7OWXQ5bsWQhnjMF0t94RLOb8i33-BcRazPkXsxHP7pp-2_E78MVPT3L_cA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1945095801</pqid></control><display><type>article</type><title>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>He, Xiaoguang ; Xie, Mingyu ; Li, Siping ; Ye, Junqin ; Peng, Qi ; Ma, Qiang ; Lu, Xiaomei ; Zhong, Baimao</creator><creatorcontrib>He, Xiaoguang ; Xie, Mingyu ; Li, Siping ; Ye, Junqin ; Peng, Qi ; Ma, Qiang ; Lu, Xiaomei ; Zhong, Baimao</creatorcontrib><description>Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China. Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance. Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria. S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-017-2710-4</identifier><identifier>PMID: 28893195</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abuse ; Analysis ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotic resistance ; Antibiotics ; Antiinfectives and antibacterials ; Antimicrobial agents ; Antimicrobial resistance ; Bacteria ; Bacterial Infections - drug therapy ; Bacterial Infections - epidemiology ; Bacterial Infections - microbiology ; Carbapenems ; Cephalosporins ; Child, Hospitalized - statistics &amp; numerical data ; Child, Preschool ; Children ; China - epidemiology ; Chlamydia ; Chlamydia pneumoniae ; Clinical medicine ; Communities ; Community-Acquired Infections - drug therapy ; Community-Acquired Infections - epidemiology ; Community-Acquired Infections - microbiology ; Diffusion tests ; Drug resistance ; Drug Resistance, Bacterial - drug effects ; E coli ; Epidemiology ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - isolation &amp; purification ; Female ; Fluoroquinolones ; Health risks ; Hospitals ; Humans ; Infant ; Infant, Newborn ; Infants ; Infections ; Infectious diseases ; Intensive care ; Klebsiella pneumoniae ; Laboratories ; Male ; Microbial Sensitivity Tests ; Mycoplasma pneumoniae ; Pathogens ; Pediatrics ; Pneumonia ; Pseudomonas aeruginosa ; Respiratory tract ; Respiratory tract diseases ; Respiratory tract infection ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Retrospective Studies ; Sputum ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation &amp; purification ; Streptococcus ; Streptococcus infections ; Streptococcus pneumoniae ; Vancomycin</subject><ispartof>BMC infectious diseases, 2017-09, Vol.17 (1), p.614-614, Article 614</ispartof><rights>COPYRIGHT 2017 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2017</rights><rights>The Author(s). 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</citedby><cites>FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594502/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1945095801?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28893195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Xiaoguang</creatorcontrib><creatorcontrib>Xie, Mingyu</creatorcontrib><creatorcontrib>Li, Siping</creatorcontrib><creatorcontrib>Ye, Junqin</creatorcontrib><creatorcontrib>Peng, Qi</creatorcontrib><creatorcontrib>Ma, Qiang</creatorcontrib><creatorcontrib>Lu, Xiaomei</creatorcontrib><creatorcontrib>Zhong, Baimao</creatorcontrib><title>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China. Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance. Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria. S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.</description><subject>Abuse</subject><subject>Analysis</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bacteria</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - epidemiology</subject><subject>Bacterial Infections - microbiology</subject><subject>Carbapenems</subject><subject>Cephalosporins</subject><subject>Child, Hospitalized - statistics &amp; numerical data</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>China - epidemiology</subject><subject>Chlamydia</subject><subject>Chlamydia pneumoniae</subject><subject>Clinical medicine</subject><subject>Communities</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Diffusion tests</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>E coli</subject><subject>Epidemiology</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - isolation &amp; purification</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Health risks</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Intensive care</subject><subject>Klebsiella pneumoniae</subject><subject>Laboratories</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Mycoplasma pneumoniae</subject><subject>Pathogens</subject><subject>Pediatrics</subject><subject>Pneumonia</subject><subject>Pseudomonas aeruginosa</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Respiratory tract infection</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Retrospective Studies</subject><subject>Sputum</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation &amp; purification</subject><subject>Streptococcus</subject><subject>Streptococcus infections</subject><subject>Streptococcus pneumoniae</subject><subject>Vancomycin</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkstu1DAUhiMEoqXwAGyQJTatRIrt3OwN0mi4jVSpEret5dhOxqPEntoOZXgf3pMTppQOYoGycHT8nd8-v_8se0rwOSGsfhkJZQ3PMWly2hCcl_eyY1I2JKdFUd6_83-UPYpxgwFklD_MjihjvCC8Os5-LFyyo1XBt1YOKJhoY5JOGWQdaqVKJsz1rUxr3xsXkRy969Hax61NcrDfjUZqbQcdjEPXNq2R8uM4OZt2SKqryQYABn9twqy9tUEmH3YoBZCGIzqjkvUgC6e9BuF-ku4FWq6tk-iUYgLXx6Q-e5w96OQQzZOb9ST7_PbNp-X7_OLy3Wq5uMhVTVnKqS4wJQVnJa5ZUROjy5Z2GuZmdadZo7hiVHHDu5aVda3bmpZUt6ToOC6ZosVJttrrai83YhvsKMNOeGnFr4IPvZAhWTUY0YD3uqpM21WyZKyRmrdKkaprDWsqLEHr1V5rO7Wj0co4GHo4ED3ccXYtev9VVBUvKzxf5vRGIPirycQkRhuVGQbpjJ-iILxghPOSlIA-_wvd-Ck4sAooEOMVw-QP1UsYAMz38zPMomIBDMGE1jVQ5_-g4NMGcuKd6SzUDxrODhqASeZb6uUUo1h9_PD_7OWXQ5bsWQhnjMF0t94RLOb8i33-BcRazPkXsxHP7pp-2_E78MVPT3L_cA</recordid><startdate>20170911</startdate><enddate>20170911</enddate><creator>He, Xiaoguang</creator><creator>Xie, Mingyu</creator><creator>Li, Siping</creator><creator>Ye, Junqin</creator><creator>Peng, Qi</creator><creator>Ma, Qiang</creator><creator>Lu, Xiaomei</creator><creator>Zhong, Baimao</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170911</creationdate><title>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</title><author>He, Xiaoguang ; Xie, Mingyu ; Li, Siping ; Ye, Junqin ; Peng, Qi ; Ma, Qiang ; Lu, Xiaomei ; Zhong, Baimao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abuse</topic><topic>Analysis</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bacteria</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - epidemiology</topic><topic>Bacterial Infections - microbiology</topic><topic>Carbapenems</topic><topic>Cephalosporins</topic><topic>Child, Hospitalized - statistics &amp; numerical data</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>China - epidemiology</topic><topic>Chlamydia</topic><topic>Chlamydia pneumoniae</topic><topic>Clinical medicine</topic><topic>Communities</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Diffusion tests</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>E coli</topic><topic>Epidemiology</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - isolation &amp; purification</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Health risks</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Intensive care</topic><topic>Klebsiella pneumoniae</topic><topic>Laboratories</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Mycoplasma pneumoniae</topic><topic>Pathogens</topic><topic>Pediatrics</topic><topic>Pneumonia</topic><topic>Pseudomonas aeruginosa</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Respiratory tract infection</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Retrospective Studies</topic><topic>Sputum</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation &amp; purification</topic><topic>Streptococcus</topic><topic>Streptococcus infections</topic><topic>Streptococcus pneumoniae</topic><topic>Vancomycin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Xiaoguang</creatorcontrib><creatorcontrib>Xie, Mingyu</creatorcontrib><creatorcontrib>Li, Siping</creatorcontrib><creatorcontrib>Ye, Junqin</creatorcontrib><creatorcontrib>Peng, Qi</creatorcontrib><creatorcontrib>Ma, Qiang</creatorcontrib><creatorcontrib>Lu, Xiaomei</creatorcontrib><creatorcontrib>Zhong, Baimao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints (Gale)</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Xiaoguang</au><au>Xie, Mingyu</au><au>Li, Siping</au><au>Ye, Junqin</au><au>Peng, Qi</au><au>Ma, Qiang</au><au>Lu, Xiaomei</au><au>Zhong, Baimao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2017-09-11</date><risdate>2017</risdate><volume>17</volume><issue>1</issue><spage>614</spage><epage>614</epage><pages>614-614</pages><artnum>614</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China. Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance. Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria. S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>28893195</pmid><doi>10.1186/s12879-017-2710-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2017-09, Vol.17 (1), p.614-614, Article 614
issn 1471-2334
1471-2334
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7128d55ebf5a4887ad9bcc15fbe8750a
source Publicly Available Content Database; PubMed Central
subjects Abuse
Analysis
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibiotic resistance
Antibiotics
Antiinfectives and antibacterials
Antimicrobial agents
Antimicrobial resistance
Bacteria
Bacterial Infections - drug therapy
Bacterial Infections - epidemiology
Bacterial Infections - microbiology
Carbapenems
Cephalosporins
Child, Hospitalized - statistics & numerical data
Child, Preschool
Children
China - epidemiology
Chlamydia
Chlamydia pneumoniae
Clinical medicine
Communities
Community-Acquired Infections - drug therapy
Community-Acquired Infections - epidemiology
Community-Acquired Infections - microbiology
Diffusion tests
Drug resistance
Drug Resistance, Bacterial - drug effects
E coli
Epidemiology
Escherichia coli
Escherichia coli - drug effects
Escherichia coli - isolation & purification
Female
Fluoroquinolones
Health risks
Hospitals
Humans
Infant
Infant, Newborn
Infants
Infections
Infectious diseases
Intensive care
Klebsiella pneumoniae
Laboratories
Male
Microbial Sensitivity Tests
Mycoplasma pneumoniae
Pathogens
Pediatrics
Pneumonia
Pseudomonas aeruginosa
Respiratory tract
Respiratory tract diseases
Respiratory tract infection
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - microbiology
Retrospective Studies
Sputum
Staphylococcus aureus
Staphylococcus aureus - drug effects
Staphylococcus aureus - isolation & purification
Streptococcus
Streptococcus infections
Streptococcus pneumoniae
Vancomycin
title Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20resistance%20in%20bacterial%20pathogens%20among%20hospitalized%20children%20with%20community%20acquired%20lower%20respiratory%20tract%20infections%20in%20Dongguan,%20China%20(2011-2016)&rft.jtitle=BMC%20infectious%20diseases&rft.au=He,%20Xiaoguang&rft.date=2017-09-11&rft.volume=17&rft.issue=1&rft.spage=614&rft.epage=614&rft.pages=614-614&rft.artnum=614&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-017-2710-4&rft_dat=%3Cgale_doaj_%3EA509101266%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1945095801&rft_id=info:pmid/28893195&rft_galeid=A509101266&rfr_iscdi=true